Brief: Eurobio Scientific H1 Net Profit Up At 33.1 Million Euros
12/10/2021 16:41
Oct 12 (Reuters) - EUROBIO SCIENTIFIC SA ALERS.PA :
* H1 EBITDA EUR 42.5 MILLION VERSUS EUR 20.3 MILLION YEAR
AGO
* H1 NET PROFIT EUR 33.1 MILLION VERSUS EUR 25.7 MILLION
YEAR AGO
* AT JUNE 30, 2021, CASH TOTALED EUR 73.0M AND FINANCIAL
DEBT
REPRESENTED EUR 12.6M
* EXPECTS CONTRACTION IN ITS COVID ACTIVITIES, WHICH WAS
ALREADY
UNDERWAY IN THE FIRST HALF OF THE YEAR, TO CONTINUE DURING THE
SECOND HALF OF 2021
Source text for Eikon: ID:nGNE786vbG
Further company coverage: ALERS.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Eurobio Scientific SA
See all newsBrief: Eurobio Scientific EB Development Files Public Offer For Shares
Brief: Eurobio Scientific Says At End Of June 2024, Recorded Revenues Of 73.4 Mln Euros, Compared With 59.1 Mln Euros A Year Ago
Brief: Eurobio Scientific FY Core Business Revenues Up At EUR 130 Mln
Brief: Eurobio Scientific Cancels 694,300 Treasury Shares, Representing Around 6.34% Of Share Capital
Brief: Eurobio Scientific H1 Ebitda Up To EUR 13.4 Million